Denver, CO — Jura Health, an Innosphere Ventures client company committed to health equity for rare disease patients and their families, is pleased to announce that Samba Scientific has made a strategic investment in the company. Samba Scientific, a leading scientific marketing company, with expertise in demand creation for growth-stage companies, will help Jura reach more patients with low or no-cost access to rare disease testing and crucial guidance for next steps.
On average, it takes 6 years to get an accurate diagnosis for someone suspected of having a rare disease. During this time, a patient will typically see more than 16 physicians with an average cost of $220,000 to find the diagnosis. This doesn’t have to be the case.
Jura Health dramatically shortens the lengthy diagnostic journey and reduces costs by providing at-home DNA sample collection, whole genome sequencing, and genetic counseling, delivering results in weeks rather than years. Covered by Medicaid in Colorado, the saliva-based test is accessible at no cost to Medicaid patients, including counseling and follow-up support, providing much-needed convenience and speed for rare disease patients.
Read the full article on innosphereventures.com
Share this page on social
Get the latest tips, tricks, and news
Get the latest tips, tricks, and news
Copyright © 2024 Samba Scientific. All rights reserved.
sambaHBSPTformCreate({portalId:"4491905",
formId:"c73f88f8-199b-4af7-b9f2-ebf3896649a9"
});